BIRC5 and cancer: Therefore, these findings implied that BIRC5 might be used as a biomarker associated with MDSC infiltration in multiple cancers, including HCC, and concordant overexpression of Birc5 and higher MDSC infiltration was correlated with poor prognosis of several tumors.